• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RNA修饰在性激素依赖性癌症中的免疫调节作用。

Immunomodulatory role of RNA modifications in sex hormone-dependent cancers.

作者信息

Jiang Yujia, Liang Xiaolan, Sun Hongyi, Yin Ping, Zhou Jing, Yu Chaoqin

机构信息

Gynecology Department of Traditional Chinese Medicine, The First Affiliated Hospital of Naval Medical University, Shanghai, China.

Department of Reproductive Medicine, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.

出版信息

Front Immunol. 2025 May 8;16:1513037. doi: 10.3389/fimmu.2025.1513037. eCollection 2025.

DOI:10.3389/fimmu.2025.1513037
PMID:40406121
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12095187/
Abstract

Recent studies have identified that RNA epigenetic modifications, including m6A, m1A, m5C, etc, play pivotal roles in tumor progression. These modifications influence mRNA stability, RNA processing, translational efficiency, and decoding precision. However, comprehensive reviews detailing the connection between m6A RNA modifications and hormone-dependent cancers in both male and female populations remain scarce(breast cancer, ovarian cancer, and endometrial cancer, prostate cancer). In this article, we explore the cellular and molecular roles of various RNA modifications alongside the key elements of the tumor microenvironment. We examine how these RNA modifications influence the development of hormone-dependent cancers through their impact on immune mechanisms. By enhancing our understanding of the function of RNA modifications within the immune systems of four specific tumors, we offer fresh insights for their potential applications in diagnosis and treatment.

摘要

最近的研究已经确定,包括m6A、m1A、m5C等在内的RNA表观遗传修饰在肿瘤进展中起着关键作用。这些修饰影响mRNA稳定性、RNA加工、翻译效率和解码精度。然而,详细阐述m6A RNA修饰与男性和女性人群中激素依赖性癌症(乳腺癌、卵巢癌、子宫内膜癌、前列腺癌)之间联系的全面综述仍然很少。在本文中,我们探讨了各种RNA修饰在肿瘤微环境关键要素中的细胞和分子作用。我们研究了这些RNA修饰如何通过对免疫机制的影响来影响激素依赖性癌症的发展。通过加深我们对四种特定肿瘤免疫系统内RNA修饰功能的理解,我们为其在诊断和治疗中的潜在应用提供了新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fe3/12095187/a212c106cb5c/fimmu-16-1513037-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fe3/12095187/aa6542bc8dbb/fimmu-16-1513037-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fe3/12095187/a212c106cb5c/fimmu-16-1513037-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fe3/12095187/aa6542bc8dbb/fimmu-16-1513037-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fe3/12095187/a212c106cb5c/fimmu-16-1513037-g002.jpg

相似文献

1
Immunomodulatory role of RNA modifications in sex hormone-dependent cancers.RNA修饰在性激素依赖性癌症中的免疫调节作用。
Front Immunol. 2025 May 8;16:1513037. doi: 10.3389/fimmu.2025.1513037. eCollection 2025.
2
m6A regulator-mediated methylation modifications define the immune infiltration characteristics of the tumor microenvironment in prostate adenocarcinoma.m6A 调节子介导的甲基化修饰定义了前列腺腺癌肿瘤微环境中的免疫浸润特征。
Sci Rep. 2024 Nov 23;14(1):29047. doi: 10.1038/s41598-024-77688-w.
3
Manipulating the tumour immune microenvironment by N6-methyladenosine RNA modification.通过 N6-甲基腺苷 RNA 修饰来操纵肿瘤免疫微环境。
Cancer Gene Ther. 2024 Sep;31(9):1315-1322. doi: 10.1038/s41417-024-00791-7. Epub 2024 Jun 4.
4
The role of RNA methylation in tumor immunity and its potential in immunotherapy.RNA 甲基化在肿瘤免疫中的作用及其在免疫治疗中的潜力。
Mol Cancer. 2024 Jun 20;23(1):130. doi: 10.1186/s12943-024-02041-8.
5
Writers, readers, and erasers RNA modifications and drug resistance in cancer.RNA 修饰与癌症的药物耐药性:作者、读者和橡皮擦
Mol Cancer. 2024 Aug 30;23(1):178. doi: 10.1186/s12943-024-02089-6.
6
RNA methylation and breast cancer: insights into m6A, m7G and m5C.RNA 甲基化与乳腺癌:m6A、m7G 和 m5C 的新见解。
Mol Biol Rep. 2024 Nov 29;52(1):27. doi: 10.1007/s11033-024-10138-y.
7
RNA epigenetic modifications in ovarian cancer: The changes, chances, and challenges.卵巢癌中的RNA表观遗传修饰:变化、机遇与挑战。
Wiley Interdiscip Rev RNA. 2023 Sep-Oct;14(5):e1784. doi: 10.1002/wrna.1784. Epub 2023 Feb 21.
8
Novel insight into the regulatory roles of diverse RNA modifications: Re-defining the bridge between transcription and translation.深入了解多种 RNA 修饰的调控作用:重新定义转录和翻译之间的桥梁。
Mol Cancer. 2020 Apr 17;19(1):78. doi: 10.1186/s12943-020-01194-6.
9
RNA Modifications and Epigenetics in Modulation of Lung Cancer and Pulmonary Diseases.RNA 修饰与表观遗传学在调控肺癌及肺部疾病中的作用。
Int J Mol Sci. 2021 Sep 30;22(19):10592. doi: 10.3390/ijms221910592.
10
Involvement of RNA methylation modification patterns mediated by m7G, m6A, m5C and m1A regulators in immune microenvironment regulation of Sjögren's syndrome.由m7G、m6A、m5C和m1A调控因子介导的RNA甲基化修饰模式在干燥综合征免疫微环境调节中的作用
Cell Signal. 2023 Jun;106:110650. doi: 10.1016/j.cellsig.2023.110650. Epub 2023 Mar 17.

引用本文的文献

1
Emerging implications of N6-methyladenosine in prostate cancer progression and treatment.N6-甲基腺嘌呤在前列腺癌进展和治疗中的新意义。
Cell Death Discov. 2025 Aug 19;11(1):391. doi: 10.1038/s41420-025-02680-w.
2
The functional and clinical significance of nucleoporin NUP153 across human cancers: a systematic study based on multi-omics analysis and bench work validation.核孔蛋白NUP153在人类癌症中的功能和临床意义:基于多组学分析和实验台工作验证的系统研究
Front Immunol. 2025 Jun 18;16:1613688. doi: 10.3389/fimmu.2025.1613688. eCollection 2025.

本文引用的文献

1
Tapasin assembly surveillance by the RNF185/Membralin ubiquitin ligase complex regulates MHC-I surface expression.Tapasin 组装监控由 RNF185/Membralin 泛素连接酶复合物调节 MHC-I 表面表达。
Nat Commun. 2024 Oct 1;15(1):8508. doi: 10.1038/s41467-024-52772-x.
2
RNA modification gene WDR4 facilitates tumor progression and immunotherapy resistance in breast cancer.RNA修饰基因WDR4促进乳腺癌的肿瘤进展和免疫治疗耐药性。
J Adv Res. 2025 Jun;72:333-351. doi: 10.1016/j.jare.2024.06.029. Epub 2024 Jul 2.
3
YBX1 promotes homologous recombination and resistance to platinum-induced stress in ovarian cancer by recognizing m5C modification.
YBX1 通过识别 m5C 修饰促进同源重组和对铂诱导应激的抵抗在卵巢癌中。
Cancer Lett. 2024 Aug 10;597:217064. doi: 10.1016/j.canlet.2024.217064. Epub 2024 Jun 14.
4
CAR-T therapy for ovarian cancer: Recent advances and future directions.嵌合抗原受体 T 细胞疗法治疗卵巢癌:最新进展与未来方向。
Biochem Pharmacol. 2024 Aug;226:116349. doi: 10.1016/j.bcp.2024.116349. Epub 2024 Jun 7.
5
circATAD2 mitigates CD8 T cells antitumor immune surveillance in breast cancer via IGF2BP3/mA/PD-L1 manner.环状 RNA ATAD2 通过 IGF2BP3/mA/PD-L1 途径减轻乳腺癌中 CD8 T 细胞的抗肿瘤免疫监视。
Cancer Immunol Immunother. 2024 May 15;73(7):130. doi: 10.1007/s00262-024-03705-6.
6
Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer.乳腺癌中肿瘤微环境的调节和基于免疫治疗的耐药机制。
Mol Cancer. 2024 May 7;23(1):92. doi: 10.1186/s12943-024-01990-4.
7
Co-transcriptional R-loops-mediated epigenetic regulation drives growth retardation and docetaxel chemosensitivity enhancement in advanced prostate cancer.共转录R环介导的表观遗传调控驱动晚期前列腺癌的生长迟缓并增强多西他赛化疗敏感性。
Mol Cancer. 2024 Apr 24;23(1):79. doi: 10.1186/s12943-024-01994-0.
8
Spatiotemporal architecture of immune cells and cancer-associated fibroblasts in high-grade serous ovarian carcinoma.高级别浆液性卵巢癌中免疫细胞和癌相关成纤维细胞的时空结构。
Sci Adv. 2024 Apr 19;10(16):eadk8805. doi: 10.1126/sciadv.adk8805. Epub 2024 Apr 17.
9
Optical controlled and nuclear targeted CECR2 competitor to downregulate CSF-1 for metastatic breast cancer immunotherapy.光学控制和核靶向 CECR2 竞争物下调 CSF-1 用于转移性乳腺癌免疫治疗。
Biomaterials. 2024 Jul;308:122568. doi: 10.1016/j.biomaterials.2024.122568. Epub 2024 Apr 12.
10
TSPAN8 myofibroblastic cancer-associated fibroblasts promote chemoresistance in patients with breast cancer.TSPAN8 肌成纤维细胞性癌症相关成纤维细胞促进乳腺癌患者的化疗耐药性。
Sci Transl Med. 2024 Apr 3;16(741):eadj5705. doi: 10.1126/scitranslmed.adj5705.